New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement

RSPHvsVHTETF Comparison

ETF 1
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.07%
VS
ETF 2
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
+0.07%

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) and Vanguard Health Care ETF (VHT) belong to the same industry segment: US Health Care. RSPH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, VHT's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. RSPH is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.09% for VHT. RSPH is up 16.48% year-to-date (YTD) with +$57M in YTD flows. VHT performs worse with 10.99% YTD performance, and +$106M in YTD flows. Run a side-by-side ETF comparison of RSPH and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

RSPH vs VHT performance and flow charts

Performance

-2.00.02.04.06.0%Aug 17Aug 24Aug 31Sep 8Sep 15

Cumulative Flows

-20 M0 M20 M40 M60 M80 M100 MAug 17Aug 24Aug 31Sep 8Sep 15

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/17/2026
1M3MYTD1Y3Y5Y
Perf.
RSPH
VHT
+3.25%+0.89%
+17.65%+12.82%
+16.48%+10.99%
+28.50%+26.36%
+34.15%+37.76%
+22.20%+31.94%
Flows
RSPH
VHT
+$104M+$65M
+$100M+$345M
+$57M+$106M
+$38M+$468M
-$257M-$2.16B
-$266M-$930M
Volatility and drawdown
3M1Y3Y5Y
Volatility
RSPH
VHT
+20.51%+18.11%
+16.75%+15.64%
+15.89%+14.68%
+16.80%+15.58%
Max drawdown
RSPH
VHT
-5.57%-5.63%
-10.87%-10.39%
-16.96%-16.88%
-21.91%-17.77%
Max drawdown duration
RSPH
VHT
29d29d
116d169d
434d435d
817d767d
Trading data

Create an account to view trading data

Join for free
RSPH
VHT
Last sale
9/17/2026 at 1:30 PM
$36.97
$317.03
Previous close
09/16/2026
$36.78
$314.66
Consolidated volume
09/16/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
RSPH
VHT
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Main metrics
Last update 9/17/2026 at 1:30 PM
Live
Closed
RSPH
VHT
Last price
$36.97
$317.03
1D performance
+0.52%
+0.75%
AuM$913.92 M$19.18 B
E/R0.4%0.09%
Characteristics
RSPH
VHT
Management strategyPassivePassive
ProviderInvescoVanguard
BenchmarkS&P 500 Equal Weight Health Care IndexMSCI US IMI Health Care 25/50 Index
N° of holdings59413
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2006January 26, 2004
ESGNoNo
Advertisement
Exposure

Countries

RSPH
USA
96.6%
Other
3.4%
VHT
USA
96.91%
Other
3.09%

Sectors

RSPH
Healthcare
98.34%
Other
1.66%
VHT
Healthcare
97.52%
Other
2.48%
Advertisement

Diversification

RSPH

Total weight of top 15 holdings out of 15

28.14%
VHT

Total weight of top 15 holdings out of 15

61.16%

Top 15 holdings

Data as of July 31, 2026
RSPH
Bio-Techne Corp.
2.10%
IQVIA Holdings, Inc.
2.08%
Veeva Systems, Inc.
1.95%
Charles River Laboratories International, Inc.
1.93%
Mettler-Toledo International, Inc.
1.89%
Baxter International, Inc.
1.87%
DaVita, Inc.
1.86%
Abbott Laboratories
1.86%
Incyte Corp.
1.85%
Thermo Fisher Scientific, Inc.
1.83%
Moderna, Inc.
1.82%
AbbVie, Inc.
1.79%
Universal Health Services, Inc.
1.78%
Regeneron Pharmaceuticals, Inc.
1.77%
Quest Diagnostics, Inc.
1.77%
VHT
Eli Lilly & Co.
13.37%
Johnson & Johnson
8.83%
AbbVie, Inc.
6.43%
UnitedHealth Group, Inc.
5.45%
Merck & Co., Inc.
4.67%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
3.01%
Abbott Laboratories
2.67%
Gilead Sciences, Inc.
2.34%
Pfizer Inc.
2.06%
Bristol Myers Squibb Co.
1.93%
CVS Health Corp.
1.93%
Intuitive Surgical, Inc.
1.82%
Danaher Corp.
1.80%
Vertex Pharmaceuticals, Inc.
1.76%
Frequently asked questions about RSPH and VHT

How have the RSPH and VHT ETFs performed in 2026?

As of September 17, 2026, RSPH is up 16.48% year-to-date (YTD), while VHT has returned 10.99%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or VHT?

Year-to-date, the RSPH ETF saw +$57M in flows, compared to +$106M for VHT.

Which ETF is more volatile: RSPH or VHT?

Over the past year, RSPH had a volatility of 16.75%, while VHT experienced 15.64%.

Which ETF is bigger: RSPH or VHT?

As of September 17, 2026, RSPH holds $913.92 M in assets under management (AUM), while VHT manages $19.18 B.

What sectors do the RSPH and VHT ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, VHT focuses on Healthcare.

What are the top holdings of the RSPH ETF and VHT ETF?

RSPH top holdings include Bio-Techne Corp., IQVIA Holdings, Inc. and Veeva Systems, Inc.. VHT holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: RSPH or VHT?

RSPH holds 59 securities with 28.14% of its assets in the top 15. VHT has 413 securities and a top 15 weight of 61.16%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder